|                                |
|--------------------------------|
|                                |  |
| Media Contact                  | July 29, 2015 |
| Casey Lassiter, 205-410-2777   | For Immediate Release |
| casey.lassiter@healthsouth.com |   |
|                           |   |
| Investor Relations Contact     |   |
| Mary Ann Arico, 205-969-6175   |   |
| maryann.arico@healthsouth.com  |   |

|         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | The Company's consolidated net operating revenues increased by $160.0 million, or 26.5%, in the second quarter of 2015 compared to the second quarter of 2014. Approximately $114 million of this increase resulted from the Company's acquisition of Encompass Home Health and Hospice (“Encompass”) on December 31, 2014. The remainder of the increase predominantly came from the Company's inpatient rehabilitation hospitals. Net operating revenues from the Company's hospitals were 8.6% higher for the second quarter of 2015 compared to the same quarter of 2014. |

|         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | Income from continuing operations attributable to HealthSouth per diluted share for the second quarter of 2015 was $0.47 per share compared to $0.81 per share for the second quarter of 2014. Earnings per share for the second quarter of 2014 benefited by $0.26 per share due to the Company's increase in ownership and consolidation of Fairlawn Rehabilitation Hospital (“Fairlawn”) in Worcester, Massachusetts effective June 1, 2014, including the associated tax benefits of the transaction. Earnings per share for the second quarter of 2015 included an $18.8 million, or $0.11 per share, loss on early extinguishment of debt associated with the Company's redemption of its 8.125% Senior Notes due 2020 (the “2020 Notes”), as discussed below. The Company's earnings per share in the second quarter of 2015 also reflected increased depreciation and amortization resulting from the Company's capital expenditures and development activities throughout 2014 and the first half of 2015, as well as higher interest expense due to the debt used to fund the acquisition of Encompass on December 31, 2014. |

|         |                                                                                                                                                                                                                                       |
|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | Cash flows provided by operating activities were $204.9 million for the six months ended June 30, 2015 compared to $235.1 million for the six months ended June 30, 2014. This decrease primarily resulted from |

|        |
|--------|
|        |  |  |
|   |   | 1 |

----

|         |                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|---------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | Adjusted EBITDA (see attached supplemental information) for the second quarter of 2015 was $169.5 million compared to $152.7 million for the second quarter of 2014, an increase of 11.0%. Adjusted EBITDA for the second quarter of 2015 included approximately $2.6 million of gains associated with the Company's equity interest in Surgical Care Affiliates (“SCA”), its former surgery centers division. |

|         |                                                                                                                                                                                                                                                                                                                  |
|---------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | Adjusted free cash flow (see attached supplemental information) for the second quarter of 2015 was $94.5 million compared to $97.9 million for the second quarter of 2014 as the Company's continued growth in Adjusted EBITDA was offset by increases in net working capital and cash interest expense. |

|         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | Net operating revenues for the inpatient rehabilitation segment were $645.3 million for the second quarter of 2015 compared to $597.1 million for the second quarter of 2014, an increase of 8.1%. This increase was attributable to an 8.3% increase in patient discharges and a 0.3% increase in net patient revenue per discharge. Discharge growth included a 2.8% increase in same-store discharges and a 5.5% increase in new-store discharges. Approximately 110 basis points of discharge growth from new stores resulted from the consolidation of Fairlawn effective June 1, 2014, with the remainder resulting from three de novo hospitals that opened in the fourth quarter of 2014 (Altamonte Springs, Florida; Newnan, Georgia; and Middletown, Delaware), the Company's acquisitions of Quillen Rehabilitation Hospital in Johnson City, Tennessee (November 2014) and Cardinal Hill Rehabilitation Hospital in Lexington, Kentucky (May 2015), and the Company's joint venture with Memorial Health in Savannah, Georgia (April 2015). While the Company experienced pricing growth from Medicare and managed care payors, these price adjustments were offset by updated Supplemental Security Income (“SSI”) ratios published by the United States Centers for Medicare and Medicaid Services (“CMS”) for fiscal year 2013 and proportionally higher discharge growth in Medicaid and managed care payors, where the Company's reimbursement is lower. The SSI ratio adjustment resulted in an approximate $5 million reduction in revenues in the second quarter of 2015 while similar ratio adjustments resulted in an approximate $2 million increase in revenues in the second quarter of 2014. |

|         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|---------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | Adjusted EBITDA (see attached supplemental information) from the inpatient rehabilitation segment for the second quarter of 2015 was $170.5 million compared to $174.7 million for the second quarter of 2014. The decrease in Adjusted EBITDA in the second quarter of 2015 compared to the second quarter of 2014 primarily resulted from the SSI ratio adjustments and proportionally higher growth in discharges from payors with lower reimbursement, as discussed above, an approximate $4 million increase in group medical insurance reserves, increased bad debt expense, and incremental costs associated with investments in the Company's operating platform, including a contractual increase in costs associated with the ongoing implementation of its electronic clinical information system, the addition of staff at hospitals to ensure compliance with new CMS quality reporting requirements, the creation of a new medical services department, and costs associated with its participation in CMS’ Model 3 bundling pilot initiative. |

|        |
|--------|
|        |  |  |
|   |   | 2 |

----

|         |                                                                                                                            |
|---------|----------------------------------------------------------------------------------------------------------------------------|
| • | began operating an inpatient rehabilitation hospital in Savannah, Georgia with its joint venture partner, Memorial Health; |

|         |                                                                        |
|---------|------------------------------------------------------------------------|
| • | acquired Cardinal Hill Rehabilitation Hospital in Lexington, Kentucky; |

|         |                                                                                    |
|---------|------------------------------------------------------------------------------------|
| • | entered into four joint venture agreements for inpatient rehabilitation hospitals; |

|         |                                                   |
|---------|---------------------------------------------------|
| • | continued development of three de novo hospitals; |

|         |                                              |
|---------|----------------------------------------------|
| • | acquired five new home health locations; and |

|         |                                      |
|---------|--------------------------------------|
| • | opened one new home health location. |

|        |
|--------|
|        |  |  |
|   |   | 3 |

----

|         |                                  |
|---------|----------------------------------|
| • | atypical litigation settlements; |

|         |                                                               |
|---------|---------------------------------------------------------------|
| • | retroactive adjustments resulting from updates to SSI ratios; |

|         |                                                 |
|---------|-------------------------------------------------|
| • | increased group medical insurance reserves; and |

|         |                                                                                                                                                                                                                                                     |
|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | increased bad debt expense resulting from additional pre-payment claims denials by Medicare Administrative Contractors and continued delays of approximately three years in the adjudication process at the administrative law judge hearing level. |

----

|                                                              |
|--------------------------------------------------------------|
|                                                              |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|                                                         | Three Months Ended June 30, |   | Six Months Ended June 30, |
|                                                         | 2015 |   | 2014 |   | 2015 |   | 2014 |
|                                                         | (In Millions) |
| Net operating revenues                                       | $ | 764.4 |  |   | $ | 604.4 |  |   | $ | 1,505.0 |  |   | $ | 1,195.6 |  |
| Less: Provision for doubtful accounts                        | (10.9 | ) |   | (9.3 | ) |   | (22.5 | ) |   | (16.8 | ) |
| Net operating revenues less provision for doubtful accounts  | 753.5 |  |   | 595.1 |  |   | 1,482.5 |  |   | 1,178.8 |  |
| Operating expenses:                                          |   |  |   |   |  |   |   |   |   |
| Salaries and benefits                                        | 401.8 |  |   | 285.3 |  |   | 786.9 |  |   | 571.4 |  |
| Other operating expenses                                     | 104.2 |  |   | 86.3 |  |   | 207.4 |  |   | 170.8 |  |
| Occupancy costs                                              | 12.5 |  |   | 10.3 |  |   | 24.6 |  |   | 20.8 |  |
| Supplies                                                     | 31.7 |  |   | 27.8 |  |   | 63.1 |  |   | 55.4 |  |
| General and administrative expenses                          | 32.1 |  |   | 30.2 |  |   | 66.7 |  |   | 60.9 |  |
| Depreciation and amortization                                | 32.7 |  |   | 26.4 |  |   | 64.6 |  |   | 52.8 |  |
| Government, class action, and related settlements            | — |  |   | (0.8 | ) |   | 8.0 |  |   | (0.8 | ) |
| Professional fees—accounting, tax, and legal           | 0.1 |  |   | 2.0 |  |   | 2.3 |  |   | 3.6 |  |
| Total operating expenses                                     | 615.1 |  |   | 467.5 |  |   | 1,223.6 |  |   | 934.9 |  |
| Loss on early extinguishment of debt                         | 18.8 |  |   | — |  |   | 20.0 |  |   | — |  |
| Interest expense and amortization of debt discounts and fees | 30.9 |  |   | 27.8 |  |   | 62.7 |  |   | 55.7 |  |
| Other income                                                 | (3.0 | ) |   | (28.2 | ) |   | (3.5 | ) |   | (29.9 | ) |
| Equity in net income of nonconsolidated affiliates           | (2.3 | ) |   | (2.6 | ) |   | (3.9 | ) |   | (6.9 | ) |
| Income from continuing operations before income tax expense  | 94.0 |  |   | 130.6 |  |   | 183.6 |  |   | 225.0 |  |
| Provision for income tax expense                             | 32.2 |  |   | 36.5 |  |   | 62.5 |  |   | 69.3 |  |
| Income from continuing operations                            | 61.8 |  |   | 94.1 |  |   | 121.1 |  |   | 155.7 |  |
| (Loss) income from discontinued operations, net of tax       | (1.6 | ) |   | 3.8 |  |   | (1.9 | ) |   | 3.7 |  |
| Net income                                                   | 60.2 |  |   | 97.9 |  |   | 119.2 |  |   | 159.4 |  |
| Less: Net income attributable to noncontrolling interests    | (17.3 | ) |   | (14.8 | ) |   | (33.8 | ) |   | (29.6 | ) |
| Net income attributable to HealthSouth                       | 42.9 |  |   | 83.1 |  |   | 85.4 |  |   | 129.8 |  |
| Less: Convertible perpetual preferred stock dividends        | — |  |   | (1.5 | ) |   | (1.6 | ) |   | (3.1 | ) |
| Net income attributable to HealthSouth common shareholders   | $ | 42.9 |  |   | $ | 81.6 |  |   | $ | 83.8 |  |   | $ | 126.7 |  |

|        |
|--------|
|        |  |  |
|   | (Continued) | 5 |

----

|                                                                             |
|-----------------------------------------------------------------------------|
|                                                                             |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|                                                                        | Three Months Ended June 30, |   | Six Months Ended June 30, |
|                                                                        | 2015 |   | 2014 |   | 2015 |   | 2014 |
|                                                                        | (In Millions, Except Per Share Data) |
| Weighted average common shares outstanding:                                 |   |  |   |   |  |   |   |   |   |
| Basic                                                                       | 89.8 |  |   | 86.7 |  |   | 88.4 |  |   | 87.0 |  |
| Diluted                                                                     | 101.5 |  |   | 100.6 |  |   | 101.3 |  |   | 100.8 |  |
|                                                                        |   |   |   |   |   |   |   |
| Earnings per common share:                                                  |   |   |   |   |   |   |   |
| Basic earnings per share attributable to HealthSouth common shareholders:   |   |   |   |  |   |   |   |   |
| Continuing operations                                                       | $ | 0.49 |  |   | $ | 0.89 |  |   | $ | 0.96 |  |   | $ | 1.40 |  |
| Discontinued operations                                                     | (0.02 | ) |   | 0.04 |  |   | (0.02 | ) |   | 0.04 |  |
| Net income                                                                  | $ | 0.47 |  |   | $ | 0.93 |  |   | $ | 0.94 |  |   | $ | 1.44 |  |
| Diluted earnings per share attributable to HealthSouth common shareholders: |   |   |   |   |   |   |   |
| Continuing operations                                                       | $ | 0.47 |  |   | $ | 0.81 |  |   | $ | 0.91 |  |   | $ | 1.29 |  |
| Discontinued operations                                                     | (0.02 | ) |   | 0.04 |  |   | (0.02 | ) |   | 0.04 |  |
| Net income                                                                  | $ | 0.45 |  |   | $ | 0.85 |  |   | $ | 0.89 |  |   | $ | 1.33 |  |
|                                                                        |   |   |   |   |   |   |   |
| Cash dividends per common share                                             | $ | 0.21 |  |   | $ | 0.18 |  |   | $ | 0.42 |  |   | $ | 0.36 |  |
|                                                                        |   |   |   |   |   |   |   |
| Amounts attributable to HealthSouth common shareholders:                    |   |   |   |  |   |   |   |   |
| Income from continuing operations                                           | $ | 44.5 |  |   | $ | 79.3 |  |   | $ | 87.3 |  |   | $ | 126.1 |  |
| (Loss) income from discontinued operations, net of tax                      | (1.6 | ) |   | 3.8 |  |   | (1.9 | ) |   | 3.7 |  |
| Net income attributable to HealthSouth                                      | $ | 42.9 |  |   | $ | 83.1 |  |   | $ | 85.4 |  |   | $ | 129.8 |  |

|        |
|--------|
|        |  |  |
|   |   | 6 |

----

|                                                                                             |
|---------------------------------------------------------------------------------------------|
|                                                                                             |  |  |  |  |  |  |  |
|                                                                                        | June 30, 2015 |   | December 31, 2014 |
|                                                                                        | (In Millions) |
| Assets                                                                                      |   |   |   |
| Current assets:                                                                             |   |   |   |
| Cash and cash equivalents                                                                   | $ | 45.5 |  |   | $ | 66.7 |  |
| Accounts receivable, net of allowance for doubtful accounts of $26.1 in 2015; $22.2 in 2014 | 351.8 |  |   | 323.2 |  |
| Deferred income tax assets                                                                  | 188.4 |  |   | 188.4 |  |
| Other current assets                                                                        | 126.7 |  |   | 108.3 |  |
| Total current assets                                                                        | 712.4 |  |   | 686.6 |  |
| Property and equipment, net                                                                 | 1,062.8 |  |   | 1,019.7 |  |
| Goodwill                                                                                    | 1,097.5 |  |   | 1,084.0 |  |
| Intangible assets, net                                                                      | 325.5 |  |   | 306.1 |  |
| Deferred income tax assets                                                                  | 79.7 |  |   | 129.4 |  |
| Other long-term assets                                                                      | 191.6 |  |   | 183.0 |  |
| Total assets                                                                                | $ | 3,469.5 |  |   | $ | 3,408.8 |  |
| Liabilities and Shareholders’ Equity                                                  |   |   |   |
| Current liabilities:                                                                        |   |   |   |
| Current portion of long-term debt                                                           | $ | 21.4 |  |   | $ | 20.8 |  |
| Accounts payable                                                                            | 60.0 |  |   | 53.4 |  |
| Accrued expenses and other current liabilities                                              | 283.2 |  |   | 290.1 |  |
| Total current liabilities                                                                   | 364.6 |  |   | 364.3 |  |
| Long-term debt, net of current portion                                                      | 2,104.4 |  |   | 2,110.8 |  |
| Other long-term liabilities                                                                 | 137.3 |  |   | 136.3 |  |
|                                                                                        | 2,606.3 |  |   | 2,611.4 |  |
| Commitments and contingencies                                                               |   |   |   |
| Convertible perpetual preferred stock                                                       | — |  |   | 93.2 |  |
| Redeemable noncontrolling interests                                                         | 98.5 |  |   | 84.7 |  |
| Shareholders’ equity:                                                                 |   |  |   |   |  |
| HealthSouth shareholders’ equity                                                      | 605.9 |  |   | 473.2 |  |
| Noncontrolling interests                                                                    | 158.8 |  |   | 146.3 |  |
| Total shareholders’ equity                                                            | 764.7 |  |   | 619.5 |  |
| Total liabilities and shareholders’ equity                                            | $ | 3,469.5 |  |   | $ | 3,408.8 |  |

|        |
|--------|
|        |  |  |
|   |   | 7 |

----

|                                                                                         |
|-----------------------------------------------------------------------------------------|
|                                                                                         |  |  |  |  |  |  |  |
|                                                                                    | Six Months Ended June 30, |
|                                                                                    | 2015 |  | 2014 |
|                                                                                    | (In Millions) |
| Cash flows from operating activities:                                                   |   |   |   |
| Net income                                                                              | $ | 119.2 |  |   | $ | 159.4 |  |
| Loss (income) from discontinued operations                                              | 1.9 |  |   | (3.7 | ) |
| Adjustments to reconcile net income to net cash provided by operating activities— |   |  |   |   |  |
| Provision for doubtful accounts                                                         | 22.5 |  |   | 16.8 |  |
| Depreciation and amortization                                                           | 64.6 |  |   | 52.8 |  |
| Loss on early extinguishment of debt                                                    | 20.0 |  |   | — |  |
| Equity in net income of nonconsolidated affiliates                                      | (3.9 | ) |   | (6.9 | ) |
| Distributions from nonconsolidated affiliates                                           | 3.7 |  |   | 6.5 |  |
| Stock-based compensation                                                                | 15.6 |  |   | 14.3 |  |
| Deferred tax expense                                                                    | 55.6 |  |   | 62.7 |  |
| Gain on consolidation of Fairlawn Rehabilitation Hospital                               | — |  |   | (27.2 | ) |
| Other                                                                                   | 11.0 |  |   | 6.1 |  |
| Change in assets and liabilities—                                                 |   |   |   |  |
| Accounts receivable                                                                     | (62.1 | ) |   | (35.6 | ) |
| Other assets                                                                            | (6.5 | ) |   | 8.4 |  |
| Accounts payable                                                                        | 1.7 |  |   | 2.7 |  |
| Accrued payroll                                                                         | (23.6 | ) |   | (15.1 | ) |
| Other liabilities                                                                       | (10.7 | ) |   | (4.9 | ) |
| Premium received on bond issuance                                                       | 8.0 |  |   | — |  |
| Premium paid on redemption of bonds                                                     | (11.8 | ) |   | — |  |
| Net cash used in operating activities of discontinued operations                        | (0.3 | ) |   | (1.2 | ) |
| Total adjustments                                                                       | 83.8 |  |   | 79.4 |  |
| Net cash provided by operating activities                                               | 204.9 |  |   | 235.1 |  |
|                                                                                    |   |   |   |

|        |
|--------|
|        |  |  |
|   | (Continued) | 8 |

----

|                                                                           |
|---------------------------------------------------------------------------|
|                                                                           |  |  |  |  |  |  |  |
|                                                                      | Six Months Ended June 30, |
|                                                                      | 2015 |   | 2014 |
|                                                                      | (In Millions) |
| Cash flows from investing activities:                                     |   |   |   |
| Purchases of property and equipment                                       | (46.3 | ) |   | (89.5 | ) |
| Capitalized software costs                                                | (15.2 | ) |   | (11.0 | ) |
| Acquisitions of businesses, net of cash acquired                          | (77.7 | ) |   | (15.9 | ) |
| Net change in restricted cash                                             | 13.1 |  |   | 6.5 |  |
| Other                                                                     | (0.6 | ) |   | 2.9 |  |
| Net cash used in investing activities                                     | (126.7 | ) |   | (107.0 | ) |
|                                                                      |   |   |   |
| Cash flows from financing activities:                                     |   |   |   |
| Proceeds from bond issuance                                               | 700.0 |  |   | — |  |
| Principal payments on debt, including pre-payments                        | (546.1 | ) |   | — |  |
| Borrowings on revolving credit facility                                   | 270.0 |  |   | 65.0 |  |
| Payments on revolving credit facility                                     | (442.0 | ) |   | (95.0 | ) |
| Debt amendment and issuance costs                                         | (13.9 | ) |   | — |  |
| Repurchases of common stock, including fees and expenses                  | — |  |   | (43.1 | ) |
| Dividends paid on common stock                                            | (37.1 | ) |   | (31.6 | ) |
| Dividends paid on convertible perpetual preferred stock                   | (3.1 | ) |   | (3.1 | ) |
| Distributions paid to noncontrolling interests of consolidated affiliates | (26.2 | ) |   | (25.4 | ) |
| Other                                                                     | (1.0 | ) |   | 6.4 |  |
| Net cash used in financing activities                                     | (99.4 | ) |   | (126.8 | ) |
| (Decrease) increase in cash and cash equivalents                          | (21.2 | ) |   | 1.3 |  |
| Cash and cash equivalents at beginning of period                          | 66.7 |  |   | 64.5 |  |
| Cash and cash equivalents at end of period                                | $ | 45.5 |  |   | $ | 65.8 |  |
|                                                                      |   |   |   |
| Supplemental schedule of noncash financing activity:                      |   |   |   |
| Conversion of preferred stock to common stock                             | $ | 93.2 |  |   | $ | — |  |

|        |
|--------|
|        |  |  |
|   |   | 9 |

----

|                                                 |
|-------------------------------------------------|
|                                                 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|                                            | Three Months Ended June 30, |   | Six Months Ended June 30, |
|                                            | 2015 |   | 2014 |   | 2015 |   | 2014 |
|                                            | (In Millions) |
| Net operating revenues:                         |   |   |   |   |   |   |   |
| Inpatient                                       | $ | 618.7 |  |   | $ | 569.7 |  |   | $ | 1,225.3 |  |   | $ | 1,127.9 |  |
| Outpatient and other                            | 26.6 |  |   | 27.4 |  |   | 50.3 |  |   | 53.7 |  |
| Total inpatient rehabilitation segment revenues | $ | 645.3 |  |   | $ | 597.1 |  |   | $ | 1,275.6 |  |   | $ | 1,181.6 |  |
|                                            |   |   |   |   |   |   |   |
|                                            | (Actual Amounts) |
| Discharges                                      | 36,408 |  |   | 33,620 |  |   | 71,524 |  |   | 66,509 |  |
| Net patient revenue per discharge               | $ | 16,994 |  |   | $ | 16,945 |  |   | $ | 17,131 |  |   | $ | 16,959 |  |
| Outpatient visits                               | 144,914 |  |   | 149,664 |  |   | 276,267 |  |   | 292,357 |  |
| Average length of stay (in days)                | 13.0 |  |   | 13.1 |  |   | 13.1 |  |   | 13.3 |  |
| Occupancy %                                     | 70.4 | % |   | 70.5 | % |   | 70.2 | % |   | 70.9 | % |
| # of licensed beds                              | 7,374 |  |   | 6,884 |  |   | 7,374 |  |   | 6,884 |  |
| Full-time equivalents                           | 17,601 |  |   | 16,251 |  |   | 17,302 |  |   | 16,164 |  |
| Employees per occupied bed                      | 3.41 |  |   | 3.37 |  |   | 3.36 |  |   | 3.33 |  |

|        |
|--------|
|        |  |  |
|   |   | 10 |

----

|                                                |
|------------------------------------------------|
|                                                |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|                                           | Three Months Ended June 30, |   | Six Months Ended June 30, |
|                                           | 2015 |   | 2014 |   | 2015 |   | 2014 |
|                                           | (In Millions) |
| Net operating revenues:                        |   |   |   |   |   |   |   |
| Home health                                    | $ | 111.5 |  |   | $ | 7.3 |  |   | $ | 215.4 |  |   | $ | 14.0 |  |
| Hospice                                        | 7.6 |  |   | — |  |   | 14.0 |  |   | — |  |
| Total home health and hospice segment revenues | $ | 119.1 |  |   | $ | 7.3 |  |   | $ | 229.4 |  |   | $ | 14.0 |  |
|                                           |   |   |   |   |   |   |   |
|                                           | (Actual Amounts) |
| Home health:                                   |   |   |   |   |   |   |   |
| Admissions                                     | 16,862 |  |   | 1,913 |  |   | 33,361 |  |   | 3,813 |  |
| Recertifications                               | 15,103 |  |   | 242 |  |   | 29,588 |  |   | 479 |  |
| Episodes                                       | 31,817 |  |   | 2,097 |  |   | 61,329 |  |   | 4,132 |  |
| Average revenue per episode                    | $ | 3,082 |  |   | $ | 3,387 |  |   | $ | 3,092 |  |   | $ | 3,284 |  |
| Episodic visits per episode                    | 19.4 |  |   | 18.4 |  |   | 19.5 |  |   | 18.5 |  |
| Total visits                                   | 675,095 |  |   | 39,876 |  |   | 1,306,094 |  |   | 79,353 |  |
| Cost per visit                                 | $ | 71 |  |   | $ | 106 |  |   | $ | 71 |  |   | $ | 107 |  |
| Hospice:                                       |   |   |   |   |   |   |   |
| Admissions                                     | 594 |  |   | N/A |  |   | 1,218 |  |   | N/A |  |
| Patient days                                   | 49,272 |  |   | N/A |  |   | 90,170 |  |   | N/A |  |
| Revenue per day                                | $ | 154 |  |   | N/A |  |   | $ | 155 |  |   | N/A |  |

|        |
|--------|
|        |  |  |
|   |   | 11 |

----

|                                                                 |
|-----------------------------------------------------------------|
|                                                                 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|                                                            | Three Months Ended June 30, 2015 |
|                                                            | Inpatient Rehabilitation |   | Home Health and Hospice |   | Reclassifications |   | HealthSouth Consolidated |
|                                                            | (In Millions) |
| Net operating revenues                                          | $ | 645.3 |  |   | $ | 119.1 |  |   | $ | — |  |   | $ | 764.4 |  |
| Less: Provision for doubtful accounts                           | (10.2 | ) |   | (0.7 | ) |   | — |  |   | (10.9 | ) |
| Net operating revenues less provision for doubtful accounts     | 635.1 |  |   | 118.4 |  |   | — |  |   | 753.5 |  |
| Operating expenses:                                             |   |   |   |   |   |   |   |
| Inpatient rehabilitation:                                       |   |   |   |   |   |   |   |
| Salaries and benefits                                           | 317.6 |  |   | — |  |   | 84.2 |  |   | 401.8 |  |
| Other operating expenses (1)                                    | 93.5 |  |   | — |  |   | 9.9 |  |   | 103.4 |  |
| Supplies                                                        | 29.9 |  |   | — |  |   | 1.8 |  |   | 31.7 |  |
| Occupancy costs                                                 | 10.7 |  |   | — |  |   | 1.8 |  |   | 12.5 |  |
| Home health and hospice:                                        |   |   |   |   |   |   |   |
| Cost of services sold (excluding depreciation and amortization) | — |  |   | 56.7 |  |   | (56.7 | ) |   | — |  |
| Support and overhead costs                                      | — |  |   | 41.0 |  |   | (41.0 | ) |   | — |  |
|                                                            | 451.7 |  |   | 97.7 |  |   | — |  |   | 549.4 |  |
| Other income                                                    | (0.4 | ) |   | — |  |   | — |  |   | (0.4 | ) |
| Equity in net income of nonconsolidated affiliates              | (2.3 | ) |   | — |  |   | — |  |   | (2.3 | ) |
| Noncontrolling interests                                        | 15.6 |  |   | 1.7 |  |   | — |  |   | 17.3 |  |
| Adjusted EBITDA — segment level                           | $ | 170.5 |  |   | $ | 19.0 |  |   | $ | — |  |   | 189.5 |  |
| General and administrative expenses (2)(3)                      |   |   |   |   |   |   | 22.6 |  |
| Gain related to SCA equity interest                             |   |   |   |   |   |   | (2.6 | ) |
| Adjusted EBITDA                                                 |   |   |   |   |   |   | $ | 169.5 |  |
|                                                            |   |   |   |   |   |   |   |
| In arriving at Adjusted EBITDA, the following were excluded:    |
| (1) Net loss (gain) on disposal or impairment of assets    | $ | 0.9 |  |   | $ | (0.1 | ) |   | $ | — |  |   | $ | 0.8 |  |
| (2) Stock-based compensation expense                       | — |  |   | — |  |   | — |  |   | 6.2 |  |
| (3) Reliant transaction costs                              | — |  |   | — |  |   | — |  |   | 3.3 |  |

|        |
|--------|
|        |  |  |
|   |   | 12 |

----

|                                                                    |
|--------------------------------------------------------------------|
|                                                                    |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|                                                               | Three Months Ended June 30, 2014 |
|                                                               | Inpatient Rehabilitation |   | Home Health and Hospice |   | Reclassifications |   | HealthSouth Consolidated |
|                                                               | (In Millions) |
| Net operating revenues                                             | $ | 597.1 |  |   | $ | 7.3 |  |   | $ | — |  |   | $ | 604.4 |  |
| Less: Provision for doubtful accounts                              | (9.2 | ) |   | (0.1 | ) |   | — |  |   | (9.3 | ) |
| Net operating revenues less provision for doubtful accounts        | 587.9 |  |   | 7.2 |  |   | — |  |   | 595.1 |  |
| Operating expenses:                                                |   |   |   |   |   |   |   |
| Inpatient rehabilitation:                                          |   |   |   |   |   |   |   |
| Salaries and benefits                                              | 280.2 |  |   | — |  |   | 5.1 |  |   | 285.3 |  |
| Other operating expenses (1)                                       | 84.0 |  |   | — |  |   | 0.6 |  |   | 84.6 |  |
| Supplies                                                           | 27.7 |  |   | — |  |   | 0.1 |  |   | 27.8 |  |
| Occupancy costs                                                    | 10.2 |  |   | — |  |   | 0.1 |  |   | 10.3 |  |
| Home health and hospice:                                           |   |   |   |   |   |   |   |
| Cost of services sold (excluding depreciation and amortization)    | — |  |   | 4.2 |  |   | (4.2 | ) |   | — |  |
| Support and overhead costs                                         | — |  |   | 1.7 |  |   | (1.7 | ) |   | — |  |
|                                                               | 402.1 |  |   | 5.9 |  |   | — |  |   | 408.0 |  |
| Other income (2)                                                   | (1.0 | ) |   | — |  |   | — |  |   | (1.0 | ) |
| Equity in net income of nonconsolidated affiliates                 | (2.6 | ) |   | — |  |   | — |  |   | (2.6 | ) |
| Noncontrolling interests                                           | 14.7 |  |   | 0.1 |  |   | — |  |   | 14.8 |  |
| Adjusted EBITDA — segment level                              | $ | 174.7 |  |   | $ | 1.2 |  |   | $ | — |  |   | 175.9 |  |
| General and administrative expenses (3)                            |   |   |   |   |   |   | 23.2 |  |
| Adjusted EBITDA                                                    |   |   |   |   |   |   | $ | 152.7 |  |
|                                                               |   |   |   |   |   |   |   |
| In arriving at Adjusted EBITDA, the following were excluded:       |
| (1) Net loss on disposal or impairment of assets              | $ | 1.7 |  |   | $ | — |  |   | $ | — |  |   | $ | 1.7 |  |
| (2) Gain on consolidation of Fairlawn Rehabilitation Hospital | 27.2 |  |   | — |  |   | — |  |   | 27.2 |  |
| (3) Stock-based compensation expense                          | — |  |   | — |  |   | — |  |   | 7.0 |  |

|        |
|--------|
|        |  |  |
|   |   | 13 |

----

|                                                                 |
|-----------------------------------------------------------------|
|                                                                 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|                                                            | Six Months Ended June 30, 2015 |
|                                                            | Inpatient Rehabilitation |   | Home Health and Hospice |   | Reclassifications |   | HealthSouth Consolidated |
|                                                            | (In Millions) |
| Net operating revenues                                          | $ | 1,275.6 |  |   | $ | 229.4 |  |   | $ | — |  |   | $ | 1,505.0 |  |
| Less: Provision for doubtful accounts                           | (21.2 | ) |   | (1.3 | ) |   | — |  |   | (22.5 | ) |
| Net operating revenues less provision for doubtful accounts     | 1,254.4 |  |   | 228.1 |  |   | — |  |   | 1,482.5 |  |
| Operating expenses:                                             |   |   |   |   |   |   |   |
| Inpatient rehabilitation:                                       |   |   |   |   |   |   |   |
| Salaries and benefits                                           | 624.0 |  |   | — |  |   | 162.9 |  |   | 786.9 |  |
| Other operating expenses (1)                                    | 188.7 |  |   | — |  |   | 19.4 |  |   | 208.1 |  |
| Supplies                                                        | 59.7 |  |   | — |  |   | 3.4 |  |   | 63.1 |  |
| Occupancy costs                                                 | 21.1 |  |   | — |  |   | 3.5 |  |   | 24.6 |  |
| Home health and hospice:                                        |   |   |   |   |   |   |   |
| Cost of services sold (excluding depreciation and amortization) | — |  |   | 110.1 |  |   | (110.1 | ) |   | — |  |
| Support and overhead costs                                      | — |  |   | 79.1 |  |   | (79.1 | ) |   | — |  |
|                                                            | 893.5 |  |   | 189.2 |  |   | — |  |   | 1,082.7 |  |
| Other income                                                    | (0.9 | ) |   | — |  |   | — |  |   | (0.9 | ) |
| Equity in net income of nonconsolidated affiliates              | (3.9 | ) |   | — |  |   | — |  |   | (3.9 | ) |
| Noncontrolling interests                                        | 30.8 |  |   | 3.0 |  |   | — |  |   | 33.8 |  |
| Adjusted EBITDA — segment level                           | $ | 334.9 |  |   | $ | 35.9 |  |   | $ | — |  |   | 370.8 |  |
| General and administrative expenses (2)(3)                      |   |   |   |   |   |   | 47.8 |  |
| Gain related to SCA equity interest                             |   |   |   |   |   |   | (2.6 | ) |
| Adjusted EBITDA                                                 |   |   |   |   |   |   | $ | 325.6 |  |
|                                                            |   |   |   |   |   |   |   |
| In arriving at Adjusted EBITDA, the following were excluded:    |
| (1) Net gain on disposal or impairment of assets           | $ | (0.6 | ) |   | $ | (0.1 | ) |   | $ | — |  |   | $ | (0.7 | ) |
| (2) Stock-based compensation expense                       | — |  |   | — |  |   | — |  |   | 15.6 |  |
| (3) Reliant transaction costs                              | — |  |   | — |  |   | — |  |   | 3.3 |  |

|        |
|--------|
|        |  |  |
|   |   | 14 |

----

|                                                                    |
|--------------------------------------------------------------------|
|                                                                    |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|                                                               | Six Months Ended June 30, 2014 |
|                                                               | Inpatient Rehabilitation |   | Home Health and Hospice |   | Reclassifications |   | HealthSouth Consolidated |
|                                                               | (In Millions) |
| Net operating revenues                                             | $ | 1,181.6 |  |   | $ | 14.0 |  |   | $ | — |  |   | $ | 1,195.6 |  |
| Less: Provision for doubtful accounts                              | (16.6 | ) |   | (0.2 | ) |   | — |  |   | (16.8 | ) |
| Net operating revenues less provision for doubtful accounts        | 1,165.0 |  |   | 13.8 |  |   | — |  |   | 1,178.8 |  |
| Operating expenses:                                                |   |   |   |   |   |   |   |
| Inpatient rehabilitation:                                          |   |   |   |   |   |   |   |
| Salaries and benefits                                              | 561.1 |  |   | — |  |   | 10.3 |  |   | 571.4 |  |
| Other operating expenses (1)                                       | 166.7 |  |   | — |  |   | 1.1 |  |   | 167.8 |  |
| Supplies                                                           | 55.2 |  |   | — |  |   | 0.2 |  |   | 55.4 |  |
| Occupancy costs                                                    | 20.6 |  |   | — |  |   | 0.2 |  |   | 20.8 |  |
| Home health and hospice:                                           |   |   |   |   |   |   |   |
| Cost of services sold (excluding depreciation and amortization)    | — |  |   | 8.4 |  |   | (8.4 | ) |   | — |  |
| Support and overhead costs                                         | — |  |   | 3.4 |  |   | (3.4 | ) |   | — |  |
|                                                               | 803.6 |  |   | 11.8 |  |   | — |  |   | 815.4 |  |
| Other income (2)                                                   | (2.7 | ) |   | — |  |   | — |  |   | (2.7 | ) |
| Equity in net income of nonconsolidated affiliates                 | (6.9 | ) |   | — |  |   | — |  |   | (6.9 | ) |
| Noncontrolling interests                                           | 29.4 |  |   | 0.2 |  |   | — |  |   | 29.6 |  |
| Adjusted EBITDA — segment level                              | $ | 341.6 |  |   | $ | 1.8 |  |   | $ | — |  |   | 343.4 |  |
| General and administrative expenses (3)                            |   |   |   |   |   |   | 46.6 |  |
| Adjusted EBITDA                                                    |   |   |   |   |   |   | $ | 296.8 |  |
|                                                               |   |   |   |   |   |   |   |
| In arriving at Adjusted EBITDA, the following were excluded:       |
| (1) Net loss on disposal or impairment of assets              | $ | 3.0 |  |   | $ | — |  |   | $ | — |  |   | $ | 3.0 |  |
| (2) Gain on consolidation of Fairlawn Rehabilitation Hospital | 27.2 |  |   | — |  |   | — |  |   | 27.2 |  |
| (3) Stock-based compensation expense                          | — |  |   | — |  |   | — |  |   | 14.3 |  |

|        |
|--------|
|        |  |  |
|   |   | 15 |

----

|                                                              |
|--------------------------------------------------------------|
|                                                              |  |  |  |  |  |  |  |  |
|                                                         | QTD |   |
|                                                         | Q2 2015 |   | Q2 2014 |   |
|                                                         | (In Millions, Except Per Share Data) |   |
| Adjusted EBITDA                                              | $ | 169.5 |  |   | $ | 152.7 |  |   |
| Interest expense and amortization of debt discounts and fees | (30.9 | ) |   | (27.8 | ) |   |
| Depreciation and amortization                                | (32.7 | ) |   | (26.4 | ) |   |
| Stock-based compensation expense                             | (6.2 | ) |   | (7.0 | ) |   |
| Noncash loss on disposal or impairment of assets             | (0.8 | ) |   | (1.7 | ) |   |
|                                                         | 98.9 |  |   | 89.8 |  |   |
| Certain nonrecurring expenses:                               |   |   |   |   |
| Government, class action, and related settlements            | — |  |   | 0.8 |  |   |
| Professional fees—accounting, tax, and legal           | (0.1 | ) |   | (2.0 | ) |   |
| Loss on early extinguishment of debt                         | (18.8 | ) |   | — |  |   |
| Reliant transaction costs                                    | (3.3 | ) |   | — |  |   |
| Gain on consolidation of Fairlawn Rehabilitation Hospital    | — |  |   | 27.2 |  |   |
| Pre-tax income                                               | 76.7 |  |   | 115.8 |  |   |
| Income tax expense (1)                                       | (32.2 | ) |   | (36.5 | ) | (2)  |
| Income from continuing operations (3)                        | $ | 44.5 |  |   | $ | 79.3 |  |   |
|                                                         |   |   |   |   |
| Basic shares                                                 | 89.8 |  |   | 86.7 |  |   |
| Diluted shares                                               | 101.5 |  |   | 100.6 |  |   |
|                                                         |   |   |   |   |
| Basic earnings per share (3)                                 | $ | 0.49 |  |   | $ | 0.89 |  |   |
| Diluted earnings per share (3)                               | $ | 0.47 |  |   | $ | 0.81 |  |   |

|           |                                                                                                                                                |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------|
| (1)  | Current income tax expense for the three months ended June 30, 2015 and 2014 was $3.4 million and $3.0 million, respectively. |

|           |                                                                                                                                                                                             |
|-----------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (2)  | The Company's effective income tax rate was reduced as a result of the nontaxable gain related to its acquisition of an additional 30% equity interest in Fairlawn Rehabilitation Hospital. |

|           |                                                                |
|-----------|----------------------------------------------------------------|
| (3)  | Income from continuing operations attributable to HealthSouth. |

|        |
|--------|
|        |  |  |
|   |   | 16 |

----

|                                                              |
|--------------------------------------------------------------|
|                                                              |  |  |  |  |  |  |  |  |
|                                                         | YTD |   |
|                                                         | Q2 2015 |   | Q2 2014 |   |
|                                                         | (In Millions, Except Per Share Data) |   |
| Adjusted EBITDA                                              | $ | 325.6 |  |   | $ | 296.8 |  |   |
| Interest expense and amortization of debt discounts and fees | (62.7 | ) |   | (55.7 | ) |   |
| Depreciation and amortization                                | (64.6 | ) |   | (52.8 | ) |   |
| Stock-based compensation expense                             | (15.6 | ) |   | (14.3 | ) |   |
| Noncash gain (loss) on disposal or impairment of assets      | 0.7 |  |   | (3.0 | ) |   |
|                                                         | 183.4 |  |   | 171.0 |  |   |
| Certain nonrecurring expenses:                               |   |   |   |   |
| Government, class action, and related settlements            | (8.0 | ) |   | 0.8 |  |   |
| Professional fees—accounting, tax, and legal           | (2.3 | ) |   | (3.6 | ) |   |
| Loss on early extinguishment of debt                         | (20.0 | ) |   | — |  |   |
| Reliant transaction costs                                    | (3.3 | ) |   | — |  |   |
| Gain on consolidation of Fairlawn Rehabilitation Hospital    | — |  |   | 27.2 |  |   |
| Pre-tax income                                               | 149.8 |  |   | 195.4 |  |   |
| Income tax expense (1)                                       | (62.5 | ) |   | (69.3 | ) | (2)  |
| Income from continuing operations (3)                        | $ | 87.3 |  |   | $ | 126.1 |  |   |
|                                                         |   |   |   |   |
| Basic shares                                                 | 88.4 |  |   | 87.0 |  |   |
| Diluted shares                                               | 101.3 |  |   | 100.8 |  |   |
|                                                         |   |   |   |   |
| Basic earnings per share (3)                                 | $ | 0.96 |  |   | $ | 1.40 |  |   |
| Diluted earnings per share (3)                               | $ | 0.91 |  |   | $ | 1.29 |  |   |

|           |                                                                                                                                              |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------|
| (1)  | Current income tax expense for the six months ended June 30, 2015 and 2014 was $6.9 million and $6.6 million, respectively. |

|           |                                                                                                                                                                                             |
|-----------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (2)  | The Company's effective income tax rate was reduced as a result of the nontaxable gain related to its acquisition of an additional 30% equity interest in Fairlawn Rehabilitation Hospital. |

|           |                                                                |
|-----------|----------------------------------------------------------------|
| (3)  | Income from continuing operations attributable to HealthSouth. |

|        |
|--------|
|        |  |  |
|   |   | 17 |

----

|                                                                                     |
|-------------------------------------------------------------------------------------|
|                                                                                     |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|                                                                                | Three Months Ended June 30, |   | Six Months Ended June 30, |
|                                                                                | 2015 |   | 2014 |   | 2015 |   | 2014 |
|                                                                                | (In Millions) |
| Net income                                                                          | $ | 60.2 |  |   | $ | 97.9 |  |   | $ | 119.2 |  |   | $ | 159.4 |  |
| Loss (income) from discontinued operations, net of tax, attributable to HealthSouth | 1.6 |  |   | (3.8 | ) |   | 1.9 |  |   | (3.7 | ) |
| Provision for income tax expense                                                    | 32.2 |  |   | 36.5 |  |   | 62.5 |  |   | 69.3 |  |
| Interest expense and amortization of debt discounts and fees                        | 30.9 |  |   | 27.8 |  |   | 62.7 |  |   | 55.7 |  |
| Professional fees—accounting, tax, and legal                                  | 0.1 |  |   | 2.0 |  |   | 2.3 |  |   | 3.6 |  |
| Government, class action, and related settlements                                   | — |  |   | (0.8 | ) |   | 8.0 |  |   | (0.8 | ) |
| Loss on early extinguishment of debt                                                | 18.8 |  |   | — |  |   | 20.0 |  |   | — |  |
| Net noncash loss (gain) on disposal or impairment of assets                         | 0.8 |  |   | 1.7 |  |   | (0.7 | ) |   | 3.0 |  |
| Depreciation and amortization                                                       | 32.7 |  |   | 26.4 |  |   | 64.6 |  |   | 52.8 |  |
| Stock-based compensation expense                                                    | 6.2 |  |   | 7.0 |  |   | 15.6 |  |   | 14.3 |  |
| Net income attributable to noncontrolling interests                                 | (17.3 | ) |   | (14.8 | ) |   | (33.8 | ) |   | (29.6 | ) |
| Reliant transaction costs                                                           | 3.3 |  |   | — |  |   | 3.3 |  |   | — |  |
| Gain on consolidation of Fairlawn Rehabilitation Hospital                           | — |  |   | (27.2 | ) |   | — |  |   | (27.2 | ) |
| Adjusted EBITDA                                                                     | $ | 169.5 |  |   | $ | 152.7 |  |   | $ | 325.6 |  |   | $ | 296.8 |  |

|        |
|--------|
|        |  |  |
|   |   | 18 |

----

|                                                                           |
|---------------------------------------------------------------------------|
|                                                                           |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|                                                                      | Three Months Ended June 30, |   | Six Months Ended June 30, |
|                                                                      |   |
|                                                                      | 2015 |   | 2014 |   | 2015 |   | 2014 |
|                                                                      | (In Millions) |
| Net cash provided by operating activities                                 | $ | 102.9 |  |   | $ | 128.0 |  |   | $ | 204.9 |  |   | $ | 235.1 |  |
| Impact of discontinued operations                                         | 0.2 |  |   | 1.0 |  |   | 0.3 |  |   | 1.2 |  |
| Net cash provided by operating activities of continuing operations        | 103.1 |  |   | 129.0 |  |   | 205.2 |  |   | 236.3 |  |
| Capital expenditures for maintenance                                      | (18.2 | ) |   | (17.6 | ) |   | (36.5 | ) |   | (47.8 | ) |
| Dividends paid on convertible perpetual preferred stock                   | (1.5 | ) |   | (1.5 | ) |   | (3.1 | ) |   | (3.1 | ) |
| Distributions paid to noncontrolling interests of consolidated affiliates | (13.0 | ) |   | (13.4 | ) |   | (26.2 | ) |   | (25.4 | ) |
| Nonrecurring items:                                                       |   |   |   |   |   |   |   |
| Net premium paid (received) on redemption/issuance of bonds               | 11.8 |  |   | — |  |   | 3.8 |  |   | — |  |
| Encompass transaction costs and related assumed liabilities               | — |  |   | — |  |   | 17.7 |  |   | — |  |
| Reliant transaction costs                                                 | 1.6 |  |   | — |  |   | 1.6 |  |   | — |  |
| Cash paid (received) for:                                                 |   |   |   |   |   |   |   |
| Professional fees—accounting, tax, and legal                        | 2.7 |  |   | 2.0 |  |   | 3.4 |  |   | 3.6 |  |
| Government, class action, and related settlements                         | 8.0 |  |   | (0.6 | ) |   | 8.0 |  |   | (0.6 | ) |
| Adjusted free cash flow                                                   | $ | 94.5 |  |   | $ | 97.9 |  |   | $ | 173.9 |  |   | $ | 163.0 |  |

|        |
|--------|
|        |  |  |
|   |   | 19 |

----

|        |
|--------|
|        |  |  |
|   |   | 20 |